The role of human-derived RNA fragments in facilitating hepatitis E virus infection

The study of hepatitis E infection has taken an interesting turn with new research suggesting the incorporation of human-derived RNA fragments into the virus genome. This discovery sheds light on why some patients develop chronic hepatitis E and why traditional medications may not always be effective.

The international research team, led by scientists from Bochum, closely monitored a patient with chronic hepatitis E over the course of a year. Through repeated sequencing of the virus RNA, they found that the virus had integrated various parts of the host’s messenger RNA into its genome. This integration provided a replication advantage, potentially contributing to the chronic nature of the infection.

Dr. Daniel Todt, the head of the Computational Virology research group at Ruhr University Bochum, stated that the insertion of host RNA could be a potential predictor for the progression of an acute infection to a chronic state. The findings of this study were published in the journal Nature Communications on June 6th, 2024.

The researchers analyzed all virus populations from the chronically infected patient over a year, examining over 180 individual sequences from blood samples. They discovered that the hepatitis E virus could incorporate host RNA into its genetic material, specifically in the hypervariable region. This alteration in the viral genome provided a replication advantage in cell culture experiments, potentially leading to chronic infection and treatment resistance.

Despite the lack of specific similarities in the incorporated gene sequences, the researchers believe that the random selection of common host RNA segments may play a crucial role in the virus’s ability to evade the immune system. This race between the virus and the immune system could determine the course of the infection, highlighting the significance of host RNA as a potential biomarker for identifying chronic hepatitis E early on in the acute phase.

The researchers plan to expand their studies to larger cohorts of patients to further understand the implications of host RNA integration in hepatitis E infection. This groundbreaking research opens new avenues for studying the mechanisms of chronic infections and developing more effective treatment strategies.

In conclusion, the integration of human-derived RNA fragments into the hepatitis E virus genome offers valuable insights into the chronic nature of the infection and the limitations of current antiviral therapies. By unraveling the role of host RNA in viral replication and immune evasion, researchers are paving the way for future advancements in the treatment of chronic hepatitis E infections.

Back To Top